Results 11 to 20 of about 72,520 (322)

Compartmentalized control of Cdk1 drives mitotic spindle assembly [PDF]

open access: yesCell Reports, 2022
Summary: During cell division, dramatic microtubular rearrangements driven by cyclin B-cdk1 (Cdk1) kinase activity mark the onset of mitosis leading to dismantling of the interphase microtubular cytoskeleton and assembly of the mitotic spindle.
Angela Flavia Serpico   +3 more
doaj   +5 more sources

DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A

open access: yesBiomolecules, 2021
DNMT3A mutations are frequently identified in acute myeloid leukemia (AML) and indicate poor prognosis. Previously, we found that the hotspot mutation DNMT3A R882H could upregulate CDK1 and induce AML in conditional knock-in mice.
Ying Yang   +4 more
doaj   +2 more sources

CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancer [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research
Background Gastric carcinoma ranks as the fifth most common cause of cancer-related mortality globally. Chemoresistance remains a critical barrier to treatment efficacy, driving poor survival outcomes in gastric cancer patients. Cyclin-dependent kinase 1
Marwah Al-Mathkour   +14 more
doaj   +2 more sources

CDK1 couples proliferation with protein synthesis

open access: yesJournal of Cell Biology, 2019
Cell proliferation exerts a high demand on protein synthesis, yet the mechanisms coupling the two processes are not fully understood. A kinase and phosphatase screen for activators of translation, based on the formation of stress granules in human cells,
Katharina Haneke   +9 more
semanticscholar   +4 more sources

Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response. [PDF]

open access: yes, 2010
The pro-apoptotic function of p53 has been well defined in preventing genomic instability and cell transformation. However, the intriguing fact that p53 contributes to a pro-survival advantage of tumor cells under DNA damage conditions raises a critical ...
Duru, Nadire   +5 more
core   +23 more sources

Suppressing CDCA8/CDK1 improves oral squamous cell carcinoma by modulating proliferation, apoptosis, cell cycle and migration [PDF]

open access: yesDiscover Oncology
We aimed to clarify the role of CDCA8/CDK1 in the progression of oral squamous cell carcinoma (OSCC) and the potential mechanisms. To explore the CDCA8 expression in OSCC, clinical samples were collected.
Jiang Zhu   +6 more
doaj   +2 more sources

COLD ATMOSPHERIC PLASMA TREATMENT MODULATES THE EXPRESSION OF cdk1, tnfα AND tp53 GENES IN HUMAN OSTEOSARCOMA CELLS

open access: yesJournal of Experimental and Molecular Biology, 2023
Osteosarcoma (OS), a malignancy primarily affecting children and adolescents, is the most frequently encountered malignant, non-hematologic, bone tumor.
Alexandru Bogdan Stache   +7 more
doaj   +1 more source

The effect of vitrification after warming on the expressions of p38, CDK1, and cyclin B in immature goat oocytes followed by in vitro maturation [PDF]

open access: yesVeterinary World, 2020
Background and Aim: The combination of vitrification techniques and in vitro maturation can reduce oocyte competence. Mitogen-activated protein kinase and maturation-promoting factor are significant in oocyte meiotic maturation regulation.
A. A. Muhammad Nur Kasman   +2 more
doaj   +1 more source

Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions

open access: yesAdvancement of science, 2023
Triple‐negative breast cancer (TNBC) is a highly lethal malignancy with limited therapy options. TWIST1, a key transcriptional factor of epithelial‐mesenchymal transition (EMT), contributes to self‐renewal of cancer stem‐like cells (CSCs), chemo ...
Tangming Guan   +14 more
semanticscholar   +1 more source

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis

open access: yesJournal of Translational Medicine, 2022
Background Adrenocortical carcinoma (ACC) is an extremely rare, aggressive tumor with few effective therapeutic options or drugs. Mitotane (Mtn), which is the only authorized therapeutic drug, came out in 1970 and is still the only first-line treatment ...
Li-wen Ren   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy